Hematopoietic stem cell transplantation activity in China 2022–2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group

Lan‐Ping Xu, Peihua Lu, Depei Wu, He Huang, Erlie Jiang, Dai‐Hong Liu, Weijie Cao, Xi Zhang, Yuewen Fu, Nainong Li, Xin-Chuan Chen, Xiaoyu Zhu, Qifa Liu, Linghui Xia, Yicheng Zhang, Yajing Xu, Fu-Chun Li, Jiong Hu, Sixi Liu, Rongrong Liu, Xiaodi Ma, Xiaowen Tang, Yi Luo, Xiao-Hui Zhang, Xiao‐Jun Huang, on behalf of the Chinese Blood and Marrow Transplantation Registry Group